Ospedale San Carlo di Nancy
Ospedale San Carlo di Nancy
Italy, Rome
Alessandro Calarco
19 anni di esperienza
Clinica certificata da :
Why choose Italy for transurethral incision of the prostate (TUIP)?
Access advanced Transurethral incision of the prostate (TUIP) solutions in trusted clinics .
| Italy | Turchia | Austria | |
| Transurethral incision of the prostate (TUIP) | - | da $2,200 | da $3,500 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi di Transurethral incision of the prostate (TUIP). Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Transurethral incision of the prostate (TUIP) al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Transurethral incision of the prostate (TUIP) e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Transurethral incision of the prostate (TUIP).
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Transurethral Incision of the Prostate (TUIP)
Day 4 to Day 7 - Post-Operation
Week 2
Week 3 - Week 6 - Rehabilitation
Week 7 Onwards
Please note, each case is individual and recovery times may vary.
Specializes in minimally invasive urological surgeries, including robotic and laparoscopic techniques for prostate conditions at Maria Cecilia Hospital.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.